Is a complete LXEO research report available?

No complete published report is available for Lexeo Therapeutics, Inc. (LXEO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · USD

$4.35

+0.04 (+0.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LXEO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	341.6M
Net income (ttm)	-87.5M
EPS (ttm)	-$1.33
Shares out	78.5M
Volume	644,632
Beta	1.43
Price target	$20.9	+380.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -87.5M
EPS (ttm): -$1.33
Market cap: 341.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LXEO indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001907108
Company name	Lexeo Therapeutics, Inc.
Country	United States
Country code	US
Cusip	52886X107
Employees	59
Employees Change	-13%
Employees Change Percent	-18.06
Enterprise value	$155.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-11-03
Isin	US52886X1072
Last refreshed	2026-07-31
Market cap	$341.6M
Market cap category	Small-Cap
Price	$4.35
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	LXEO
Website	https://www.lexeotx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.62%
FCF yield	-28.81%
P/B ratio	1.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-62.3M
Net Income	$-87.5M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-32.5
Roa5y	-37.1
ROCE	-41.41
ROE	-54.75
Roe5y	-67.2
ROIC	-36.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	6.1%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$250.4M
Cash	$193M
Current Assets	$200.9M
Current Liabilities	$14.2M
Debt	$7.4M
Debt Equity	$0.03
Equity	$231.5M
Interest Coverage	-1,164.1
Liabilities	$18.9M
Long Term Assets	$49.5M
Long Term Liabilities	$4.7M
Net Cash	$185.7M
Net Cash By Market Cap	$54.36
Net Cash Growth	105.32%
Net Debt Equity	$-0.8
Tangible Book Value	$231.5M
Tangible Book Value Per Share	$3.12
WACC	11.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.16
Net Working Capital	$-3.7M
Quick ratio	13.61
Working Capital	$186.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-98.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	6.1%
200-day SMA	6.95
50-day SMA	4.71
50-day SMA vs 200-day SMA	50under200
All Time High	22.33
All Time High Change	-80.52%
All Time High Date	2024-01-18
All Time Low	1.45
All Time Low Change	200%
All Time Low Date	2025-04-07
ATR	0.32
Beta	1.43
Beta1y	1.6
Beta2y	2.09
Ch YTD	-56.19
High	4.47
High52	10.99
High52 Date	2025-12-23
High52ch	-60.42%
Low	4.28
Low52	4.03
Low52 Date	2026-06-11
Low52ch	7.94%
Ma50ch	-7.64%
Premarket Change Percent	-0.7
Premarket Price	$4.28
Premarket Volume	2,719
Price vs 200-day SMA	-37.42%
RSI	41.5
RSI Monthly	38.73
RSI Weekly	36.55
Sharpe ratio	0.4x
Sortino ratio	0.72
Total Return	-98.55%
Tr YTD	-56.19
Tr1m	-9.56%
Tr1w	-7.64%
Tr3m	-23.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$16.4
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.28
Operating Income	$-97.8M
Price target	$20.89
Price Target Change	$380
Price Target Change Top	$277

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,418,628%
Float Percent	60.39%
Net Borrowing	-495,000
Shares Insiders	0.37%
Shares Institutions	75.25%
Shares Out	78,521,634
Shares Qo Q	6.32%
Shares Yo Y	98.55%
Short Float	34.48%
Short Ratio	15.14
Short Shares	20.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-109.6M
Adjusted OCF	-109,179,000
Average Volume	959,569.5x
Bv Per Share	3.12
CAPEX	$-432,000
Ch1m	-9.56
Ch1w	-7.64
Ch1y	6.1
Ch3m	-23.42
Ch6m	-42.54
Change	0.93%
Change From Open	-0.23
Close	4.31
Days Gap	1.16
Depreciation Amortization	601,000
Dollar Volume	2,804,149.2
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-97.8M
EBITDA	$-97.5M
EPS	$-1.33
F Score	1
FCF	$-98.4M
FCF EV Yield	-63.13x
FCF Per Share	$-1.25
Financing CF	219,236,000
Fiscal Year End	December
Founded	2,017
Investing CF	-78,392,000
Ipr	-60.45
Iprfo	-54.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	6.18
Ma150ch	-29.59%
Ma20	4.67
Ma20ch	-6.91%
Net CF	42,855,000
Next Earnings Date	2026-08-13
Open	4.36
Optionable	Yes
Position In Range	36.84
Ppne	8,346,000
Pre Close	4.31
Price Date	2026-07-30
Ptbv Ratio	1.48
Relative Volume	0.67x
Share Based Comp	11,190,000
Tr6m	-42.54%
Us State	New York
Volume	644,632

Lexeo Therapeutics, Inc. (LXEO)

Coverage state: Market snapshot only — no published research

Generate the first LXEO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LXEO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LXEO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LXEO

Frequently asked questions